IRIDEX Corporation (IRIX) financial statements and ratios from SEC XBRL: revenue $52.67M (TTM), net margin -8.4%, revenue growth -7.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $52.67M |
| Net Margin | -8.4% |
| Revenue Growth (YoY) | -7.4% |
| EPS Growth (YoY) | 16.7% |
| FCF Growth (YoY) | -130.2% |
| Price / Book | 3.66 |
| Price / Sales | 0.26 |
| FCF Yield | -21.7% |
| Altman Z-Score | -2.10 (distress) |
| Sector P/E (Healthcare) | 21.6 |
IRIX overview · IRIX earnings · IRIX KPIs · IRIX investor relations · IRIX ownership · IRIX peers · IRIX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.